Read Martin L, Logan Ann, Seymour Leonard W
Molecular Neuroscience Group, Department of Medicine, Wolfson Research Laboratories, University of Birmingham, Birmingham B15 2TH, United Kingdom.
Adv Genet. 2005;53:19-46.
Progress has been made in the development of different types of nucleic acids such as DNA and siRNA with the potential to form the basis of new treatments for genetic and acquired disorders. The lack of suitable vectors for the delivery of nucleic acids, however, represents a major hurdle to their continued development and therapeutic application. Synthetic vectors based on polycations are promising vectors for gene delivery as they are relatively safe and can be modified by the incorporation of ligands for targeting to specific cell types. However, the levels of gene expression mediated by synthetic vectors are low compared to viral vectors. The aim of this chapter is to give an overview of the main barriers that have been identified as limiting gene transfer using polycation-based synthetic vectors. The chapter is divided into two sections to focus on both extracellular and intracellular barriers. We describe novel strategies that are being used to develop increasingly sophisticated vectors in an attempt to overcome these barriers. For instance, we describe approaches to prolong the plasma circulation of polyplexes by the incorporation onto their surface of hydrophilic polymers such as polyethylene glycol (PEG) and poly[N-(2-hydroxypropyl)methacrylamide] (pHPMA). In addition, strategies to improve transfer of nucleic acids from the outside of the cell to the nucleus are described to overcome barriers such as escape from endocytic vesicles and translocation across the nuclear membrane. Furthermore, we highlight new types of vectors based on reducible polycations that are triggered by the intracellular environment to facilitate efficient cytoplasmic release of nucleic acids.
在不同类型核酸(如DNA和siRNA)的开发方面已取得进展,这些核酸有潜力成为治疗遗传疾病和后天性疾病新疗法的基础。然而,缺乏合适的核酸递送载体是其持续发展和治疗应用的主要障碍。基于聚阳离子的合成载体是很有前景的基因递送载体,因为它们相对安全,并且可以通过掺入靶向特定细胞类型的配体进行修饰。然而,与病毒载体相比,合成载体介导的基因表达水平较低。本章的目的是概述已被确定为限制使用基于聚阳离子的合成载体进行基因转移的主要障碍。本章分为两个部分,分别关注细胞外和细胞内障碍。我们描述了正在用于开发越来越复杂载体的新策略,试图克服这些障碍。例如,我们描述了通过在其表面掺入亲水性聚合物(如聚乙二醇(PEG)和聚[N-(2-羟丙基)甲基丙烯酰胺](pHPMA))来延长多聚体在血浆中循环的方法。此外,还描述了改善核酸从细胞外部转移到细胞核的策略,以克服诸如从内吞小泡逃逸和穿过核膜转运等障碍。此外,我们强调了基于可还原聚阳离子的新型载体,这些载体由细胞内环境触发,以促进核酸在细胞质中的有效释放。